![PRD_000215 PRD_000215](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000215.svg) | PRD_000215 | Name: | DIHYDROMICROCYSTIN-LA | Formula: | C46 H69 N7 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000988 PRD_000988](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000988.svg) | PRD_000988 | Name: | N-benzoyl-L-norleucyl-6-ammonio-L-norleucyl-N~5~-[amino(iminio)methyl]-N-[(2S)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-ornithinamide | Formula: | C31 H57 N11 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000224 PRD_000224](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000224.svg) | PRD_000224 | Name: | Polytheonamide B | Formula: | C219 H376 N60 O72 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001016 PRD_001016](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001016.svg) | PRD_001016 | Name: | Glidobactin | Formula: | C27 H46 N4 O6 | Definition date: | 2013-02-06 | Last modified: | 2023-11-03 |
|
![PRD_001018 PRD_001018](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001018.svg) | PRD_001018 | Name: | Cepafungin I | Formula: | C28 H48 N4 O6 | Definition date: | 2013-02-06 | Last modified: | 2023-11-03 |
|
![PRD_001021 PRD_001021](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001021.svg) | PRD_001021 | Name: | INHIBITOR ARC-670 | Formula: | C53 H103 N31 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001022 PRD_001022](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001022.svg) | PRD_001022 | Name: | (2S,5S,8S,13S,16Z)-5-benzyl-2-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxylic acid | Formula: | C36 H46 N8 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001023 PRD_001023](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001023.svg) | PRD_001023 | Name: | (2S,5S,8S,13S,16Z)-5-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-2-(3-phenylprop-2-en-1-yl)-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxamide | Formula: | C38 H49 N9 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001025 PRD_001025](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001025.svg) | PRD_001025 | Name: | Trypsin inhibitor 1 | Formula: | C67 H107 N18 O19 S2 | Definition date: | 2013-10-09 | Last modified: | 2023-11-03 |
|
![PRD_001031 PRD_001031](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001031.svg) | PRD_001031 | Name: | Microcystin-LR (MCLR) bound form | Formula: | C49 H77 N10 O12 | Definition date: | 2013-05-08 | Last modified: | 2023-11-03 |
|
![PRD_001041 PRD_001041](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001041.svg) | PRD_001041 | Name: | TMC-95A mimic ligand yCP:4e | Formula: | C61 H83 N9 O10 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001044 PRD_001044](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001044.svg) | PRD_001044 | Name: | TMC-95A mimic ligand yCP:3a | Formula: | C60 H80 N8 O11 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001047 PRD_001047](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001047.svg) | PRD_001047 | Name: | (2E,4E)-N-[(2R,3S)-1-{[(5S,8S,9E)-2,7-dioxo-5-(propan-2-yl)-1,6-diazacyclododec-9-en-8-yl]amino}-3-hydroxy-1-oxobutan-2-yl]dodeca-2,4-dienamide | Formula: | C29 H48 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001049 PRD_001049](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001049.svg) | PRD_001049 | Name: | TMC-95A mimic ligand yCP:4a chain Q | Formula: | C55 H72 N8 O9 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
![PRD_001064 PRD_001064](https://data.pdbj.org/pdbjplus/data/cc/svg/1RR.svg) | PRD_001064 | Name: | N-(tert-butylcarbamoyl)-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]-L-prolinamide | Formula: | C38 H47 N5 O7 | Definition date: | 2014-03-26 | Last modified: | 2023-11-03 |
|
![PRD_001066 PRD_001066](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001066.svg) | PRD_001066 | Name: | Muramyl tetrapeptide | Formula: | C30 H53 N8 O13 | Definition date: | 2014-03-12 | Last modified: | 2023-11-03 |
|
![PRD_001069 PRD_001069](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001069.svg) | PRD_001069 | Name: | N-acetyl-L-alanyl-L-alanyl-N-[(2S)-1-hydroxypropan-2-yl]-L-prolinamide | Formula: | C16 H28 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001071 PRD_001071](https://data.pdbj.org/pdbjplus/data/cc/svg/3SD.svg) | PRD_001071 | Name: | N~4~-(2,2-dimethylpropyl)-N~1~-{(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-aspartamide | Formula: | C32 H41 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000291 PRD_000291](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000291.svg) | PRD_000291 | Name: | BETA-SECRETASE INHIBITOR NVP-AUR200 | Formula: | C34 H61 N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000292 PRD_000292](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000292.svg) | PRD_000292 | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | Formula: | C29 H50 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001075 PRD_001075](https://data.pdbj.org/pdbjplus/data/cc/svg/P3N.svg) | PRD_001075 | Name: | N-[(2S)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-1-({(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | Formula: | C32 H38 N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000330 PRD_000330](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000330.svg) | PRD_000330 | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | Formula: | C30 H41 N5 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001107 PRD_001107](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001107.svg) | PRD_001107 | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | Formula: | C95 H147 N32 O21 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000332 PRD_000332](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000332.svg) | PRD_000332 | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | Formula: | C36 H46 N6 O13 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001125 PRD_001125](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001125.svg) | PRD_001125 | Name: | Peptide ligand | Formula: | C51 H75 N9 O14 | Definition date: | 2013-12-04 | Last modified: | 2023-11-03 |
|